Naïve CD4+ T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy

Michael Schneider

Department of Gynecology and Obstetrics, University Hospital Erlangen

Luca Paruzzo

Federico Stella

Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia

Julia Han Noll

Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia

Matthew Ho

Victor Babatunde

Bianca Ho

Pooja Devi

Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia

Elise A. Chong

Lymphoma Program, Abramson Cancer Center, Division of Hematology Oncology, Department of Medicine, University of Pennsylvania

Stefan K. Barta

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia

Sunita D. Nasta

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia

Jakub Svoboda

Institute of Science and Technology Austria

Jordan Carter

Michael R. Cook

Nasheed M. Hossain

Colin J. Thomas

Vrutti Patel

Vitor B. de Souza

Mohannad H. Alkhatib

Ziyu Li

Melody Tan

Peter Michener

Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia

Puneeth Guruprasad

Antonio Imparato

Alberto Carturan

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia

Patrizia Porazzi

Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia

Joseph A. Fraietta

Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania

Stephen J. Schuster

Lymphoma Program, Abramson Cancer Center, Division of Hematology Oncology, Department of Medicine, University of Pennsylvania

Ivan Maillard

Marco Ruella

Daniel J. Landsburg

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia